Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
828
-
Total shares
-
50.8M
-
Shares change
-
-8.71M
-
Total reported value, excl. options
-
$7.65B
-
Value change
-
-$1.31B
-
Put/Call ratio
-
2.39
-
Number of buys
-
350
-
Number of sells
-
-336
-
Price
-
$150.56
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2021
856 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2021.
ISHARES TR - ISHARES BIOTECH (IBB) has 828 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.8M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (13.5M shares), MORGAN STANLEY (6.07M shares), GOLDMAN SACHS GROUP INC (3.26M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2.66M shares), UBS Group AG (2.22M shares), CITIGROUP INC (2.19M shares), JPMORGAN CHASE & CO (2.06M shares), BNP PARIBAS ARBITRAGE, SA (1.56M shares), BARCLAYS PLC (1.21M shares), and ROYAL BANK OF CANADA (1.2M shares).
This table shows the top 828 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.